BEAT vs POM
Comparison between HeartBeam Inc (BEAT, Company) and Pomdoctor Ltd (POM, Company).
Both BEAT and POM are from the Healthcare sector.
BEAT vs POM - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
BEAT
$31M
POM
$31M
Max Drawdown
Winner
BEAT
90.19%
POM
98.77%
Sharpe Ratio
Winner
BEAT
0.16
POM
-0.00
5Y Beta
BEAT
N/A
POM
0.85
Industry
BEAT
Health Information Services
POM
Pharmaceutical Retailers
P/E Ratio
BEAT
-1.40
POM
N/A
Debt to Equity
BEAT
0.00%
POM
N/A
Free Cash Flow Yield
BEAT
-44.47%
POM
N/A
P/S Ratio
BEAT
N/A
POM
0.09
P/B Ratio
BEAT
N/A
POM
-0.01
BEAT vs POM - Historical Returns
Returns include dividend reinvestment.
1M
Winner
BEAT
-16.87%
POM
-25.37%
3M
Winner
BEAT
-48.45%
POM
-73.52%
6M
Winner
BEAT
-67.05%
POM
-75.95%
1Y
BEAT
-50.47%
POM
N/A
5Y(CAGR)
BEAT
-32.81%
POM
N/A
Max(CAGR)
Winner
BEAT
-32.81%
POM
-99.57%
BEAT vs POM - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | BEAT | POM |
|---|---|---|
| 2026 | -68.81% | -68.86% |
| 2025 | +2.13% | -92.68% |
| 2024 | -1.29% | N/A |
| 2023 | -48.91% | N/A |
| 2022 | +32.97% | N/A |
| 2021 | -34.33% | N/A |
BEAT vs POM Drawdown Comparison
The maximum drawdown for BEAT was -90.19%, occurring on Nov 25, 2025. This drawdown has not yet recovered.
The maximum drawdown for POM was -98.77%, occurring on May 8, 2026. This drawdown has not yet recovered.
The current BEAT drawdown is -87.24%. The current POM drawdown is -98.33%.
| Rank | BEAT | POM |
|---|---|---|
| #1 | -90.19% Dec 13, 2022 - Nov 25, 2025 | -98.77% Nov 6, 2025 - May 8, 2026 |
| #2 | -74.84% Nov 11, 2021 - Oct 6, 2022 | -12.37% Oct 9, 2025 - Oct 28, 2025 |
| #3 | -50.17% Oct 7, 2022 - Dec 8, 2022 | -0.73% Oct 30, 2025 - Nov 3, 2025 |
| #4 | -5.64% Dec 8, 2022 - Dec 13, 2022 | N/A |
Correlation
Correlation between BEAT and POM is 0.09 which considered as a very weak or no correlation - the stocks move independently of each other.
0.09
-101
Select Stocks to Compare
Popular: BEAT vs SPYPOM vs SPY
More Comparisons
Compare with similar stocks